On June 23, 2025, the U.S. Meals and Drug Administration (FDA) granted accelerated approval to Datroway (datopotamab deruxtecan-dlnk) for the remedy of sufferers with domestically superior or metastatic non-small cell lung most cancers (NSCLC) with an epidermal progress issue receptor (EGFR) mutation following development on or after EGFR-targeted remedy and platinum-based chemotherapy.
Notably, the TROPION-Lung05 and TROPION-Lung01 medical trials handled sufferers with this now-FDA-approved agent.
To delve deeper into the importance of this FDA approval, CURE sat down for an interview with Dr. Jacob Sands, who’s the affiliate chief of the Lowe Middle for Thoracic Oncology, oncology medical director of Worldwide Affected person Middle, and a doctor on the Dana-Farber Most cancers Institute. He additionally serves as an assistant professor at Harvard Medical College, each of that are situated in Boston, Massachusetts.
Transcript
What’s the significance of the FDA approval of Datroway for sufferers with beforehand handled EGFR-mutated NSCLC?
This represents a brand new, beforehand unused remedy possibility for sufferers who’ve NSCLC with EGFR mutations. In that setting, an array of different remedies exists, and the preliminary remedy is often a focused remedy, with a few totally different choices from which to decide on. Chemotherapy is an alternative choice that may be given together with focused remedy from the start or as a second remedy. This new remedy, datopotamab deruxtecan — the complete title is a mouthful, so we frequently say Dato-DXd, the model title being Datroway — is FDA-approved for somebody who has already had focused remedy and chemotherapy.
To put some groundwork, the chemotherapy utilized for such a lung most cancers usually doesn’t trigger hair loss. Normally, I do know folks image plenty of nausea and vomiting, however that’s not usually skilled, particularly not severely. If it happens, it is often delicate. That is simply to say that these remedies are sometimes so much simpler than what folks count on. It is to not say that anybody desires these sorts of remedies, in fact, however this has been an enormous advance.
There have been a number of advances within the discipline; I might say, from 20 years in the past, there have been drugs that forestall nausea, which made chemotherapy much better tolerated. Moreover, within the final little over 10 years, we have seen the appearance of focused therapies, and we now have an array of these. This represents the primary antibody-drug conjugate, which is a complete new class for EGFR-directed or EGFR NSCLC. Antibody-drug conjugates are an antibody that primarily binds to the tumor cells and delivers a payload, which is a form of chemotherapy or a cytotoxic agent, immediately contained in the tumor cells.
It is a method of primarily getting the chemo to these cells immediately as an alternative of extensively all through the physique.
Transcript has been edited for readability and conciseness
For extra information on most cancers updates, analysis and training, don’t overlook to subscribe to CURE®’s newsletters right here.
